{Reference Type}: Journal Article
{Title}: Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Overlap Syndrome: An Update on the Epidemiology, Pathophysiology, and Management.
{Author}: Nguyen BHM;Murphy PB;Yee BJ;
{Journal}: Sleep Med Clin
{Volume}: 19
{Issue}: 3
{Year}: 2024 Sep
暂无{DOI}: 10.1016/j.jsmc.2024.04.003
{Abstract}: This review provides an up-to-date summary of the prevalence, pathophysiology, diagnosis, and treatment of the chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) overlap syndrome (OVS). The presence of OVS is high in patients with COPD and in patients with OSA and is associated with profound nocturnal oxygen desaturation and systemic inflammation. There is a high prevalence of cardiovascular disease among patients with OVS and this likely contributes to increased mortality. Observational studies suggest that positive airway pressure therapy improves survival and reduces COPD exacerbations; however, randomized controlled trials will be required to confirm these findings.